The role of these new long-acting hydrocodone products in hospice patients will be very limited due to factors such as high cost and the availability of other long-acting opioids with established track records of efficacy in severe chronic pain (Methadone tablets and solution, Morphine Extended Release dosage-forms, etc.) Tags: zyhydro, Hysingla ER, hydrocodone, Vicodin, Lortab, , hospice drugs, h